| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.05 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |